var title_f16_17_16656="Eval chest pain abnormal exam";
var content_f16_17_16656=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F80077&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F80077&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 589px\">",
"   <div class=\"ttl\">",
"    Evaluation of pediatric chest pain - abnormal physical examination",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 569px; height: 510px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic approach to evaluation of pediatric patient with chest pain in whom the physical examination is abnormal. For details about the various conditions, see the text.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Brenner, JI, Ringel, RE, Berman, MA. Cardiologic perspectives of chest pain in childhood: a referral problem? To whom? Pediatr Clin North Am 1984; 31:1241.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16656=[""].join("\n");
var outline_f16_17_16656=null;
var title_f16_17_16657="CD40L CD40 expression";
var content_f16_17_16657=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F61633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F61633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Peripheral blood flow cytometry profile in HIGM",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 296px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CD40L (aka CD154) expression in unstimulated and stimulated CD4+ T cells. Normal individuals show CD40L upregulation, while patients with X-linked hyper IgM (XL-HIGM) syndrome do not. Carriers of the mutation show bimodal expression pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16657=[""].join("\n");
var outline_f16_17_16657=null;
var title_f16_17_16658="MRI of tethered spinal cord and lipoma";
var content_f16_17_16658=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63551&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63551&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRI of the lumbar spine showing a tethered cord and lipoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 207px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lumbar spine MRI with T1-weighted sagittal image demonstrating a tethered cord (arrow) and lipoma (asterisk) in a two-year-old girl.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16658=[""].join("\n");
var outline_f16_17_16658=null;
var title_f16_17_16659="Olsalazine: Pediatric drug information";
var content_f16_17_16659=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Olsalazine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?42/3/43059?source=see_link\">",
"    see \"Olsalazine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?43/36/44611?source=see_link\">",
"    see \"Olsalazine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F203247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dipentum&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F203248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dipentum&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060664\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       5-Aminosalicylic Acid Derivative",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anti-inflammatory Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/3/43059?source=see_link\">",
"      see \"Olsalazine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 1 g/day in 2 divided doses",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F203228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as sodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dipentum&reg;: 250 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F203213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with food in evenly divided doses",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maintenance of remission of ulcerative colitis in patients intolerant to sulfasalazine (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F203287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Olsalazine may be confused with OLANZapine",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Dipentum&reg; may be confused with Dilantin&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F203285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Depression, dizziness, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain/cramps, bloating, diarrhea (dose related), nausea, stomatitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Upper respiratory infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Alkaline phosphatase increased, Alopecia, ALT increased, anemia, angioedema, aplastic anemia, AST increased, bilirubin increased, blood in stool, blurred vision, bronchospasm, cholestatic hepatitis, cholestatic jaundice, chest pain, chills, cirrhosis, dehydration, dry eyes, dyspnea, dysuria, eosinophilia, epigastric discomfort, erythema, erythema nodosum, fever, flare of symptoms, flatulence, GGT increased, heart block (second degree), hematuria, hemolytic anemia, hepatitis, hepatic failure, hepatic necrosis, hot flashes, hypertension, impotence, insomnia, interstitial nephritis, interstitial pneumonia, irritability, jaundice, Kawasaki-like syndrome, LDH increased, leukopenia, lymphopenia, menorrhagia, mood swings, muscle cramps, myalgia, myocarditis, nephrotic syndrome, neutropenia, orthostatic hypotension, palpitation, pancreatitis, pancytopenia, paresthesia, pericarditis, peripheral edema, peripheral neuropathy, photosensitivity, proteinuria, rectal bleeding, rectal discomfort, reticulocytosis, rigors, tachycardia, thrombocytopenia, tinnitus, tremor, urinary frequency, watery eyes, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to olsalazine, salicylates, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060658\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hypersensitivity to sulfasalazine or mesalamine. Use with caution in patients with asthma, severe allergies, hepatic impairment, or renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060657\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Diarrhea is a common adverse effect of olsalazine. May exacerbate symptoms of colitis.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F203222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: 5-ASA Derivatives may decrease the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin: 5-ASA Derivatives may enhance the adverse/toxic effect of Heparin. Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin (Low Molecular Weight): 5-ASA Derivatives may enhance the adverse/toxic effect of Heparin (Low Molecular Weight). Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiopurine Analogs: 5-ASA Derivatives may decrease the metabolism of Thiopurine Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: 5-ASA Derivatives may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. The primary concern is the potential development of Reye's Syndrome, a condition that has been associated with the use of salicylates in children with varicella infections.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F203224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5357680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have demonstrated fetal developmental toxicities. There are no well-controlled studies in pregnant women. Use during pregnancy only if clearly necessary.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Olsalazine is a sodium salt of a salicylate compound that is effectively bioconverted by colonic bacteria to 5-aminosalicylic acid (5-ASA). The exact mechanism of action appears to be topical rather than systemic. It may diminish colonic inflammation by blocking cyclooxygenase and inhibiting colon prostaglandin production in the bowel mucosa.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: &lt;3%; very little intact olsalazine is systemically absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: &gt;99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Mostly by colonic bacteria to the active drug, 5-aminosalicylic acid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 2.4%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination: 54 minutes (in serum)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Primarily in feces; &lt;1% eliminated in urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060663\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?43/36/44611?source=see_link\">",
"      see \"Olsalazine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contact physician if diarrhea occurs. May cause dry mouth. May rarely cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid direct exposure to sunlight.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12657 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-33D61AF354-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16659=[""].join("\n");
var outline_f16_17_16659=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203247\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203248\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060664\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060659\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203228\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203213\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060667\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060666\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203287\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203285\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060670\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060658\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060657\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299787\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203222\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203224\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5357680\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060656\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060669\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060663\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12657\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12657|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/3/43059?source=related_link\">",
"      Olsalazine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?43/36/44611?source=related_link\">",
"      Olsalazine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_17_16660="Pathogenesis of ovarian hyperstimulation syndrome";
var content_f16_17_16660=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis of ovarian hyperstimulation syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Vaclav Insler, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Bruno Lunenfeld, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16660/contributors\">",
"     William F Crowley, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16660/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/17/16660/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 6, 2008.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian hyperstimulation syndrome (OHSS) refers to a combination of ovarian enlargement due to multiple ovarian cysts and an acute fluid shift out of the intravascular space. The ovarian cysts are the result of multifollicular development. The most severe manifestations of the syndrome include massive ovarian enlargement from multiple cysts and, due to fluid movement out of the intravascular space, hemoconcentration and third-space accumulation of fluid; these changes may be complicated by renal failure, hypovolemic shock, thromboembolic episodes, acute respiratory distress syndrome, and death [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of OHSS will be reviewed here. The classification, prevention, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35479?source=see_link\">",
"     \"Classification and treatment of ovarian hyperstimulation syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22647?source=see_link\">",
"     \"Prevention of ovarian hyperstimulation syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPONTANEOUS VERSUS INDUCED OVULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In spontaneous ovulatory cycles, hypothalamic-pituitary-ovarian feedback mechanisms limit follicle recruitment to a small number of early antral follicles. Full development is generally restricted to a single leading follicle that will ovulate in response to the midcycle luteinizing hormone (LH) surge. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=see_link\">",
"     \"Physiology of the normal menstrual cycle\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, ovulation induction involves administration of a pharmacological dose of exogenous gonadotropins, thereby overriding normal feedback mechanisms. This results in recruitment of a large number of antral follicles, several of which are sustained as leading follicles capable of either luteinization or ovulation. The monofollicular development that occurs in spontaneous cycles is extremely difficult to duplicate in stimulated cycles, even with meticulous ultrasound and serum estradiol monitoring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Exogenous gonadotropins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ovarian hyperstimulation occurs after luteinization of a large number of follicles. Such massive follicular luteinization is usually only observed in exogenous gonadotropin cycles following administration of human chorionic gonadotropin (hCG), or after administration of gonadotropin releasing hormone (GnRH) agonist; it rarely occurs in women treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"     clomiphene",
"    </a>",
"    citrate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link\">",
"     \"Ovulation induction with clomiphene citrate\"",
"    </a>",
"    .) The clinical symptoms usually appear 5 to 10 days following the first dose of the ovulatory trigger (hCG, GnRH agonist). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=see_link\">",
"     \"Overview of ovulation induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Endogenous LH surge",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild ovarian hyperstimulation also rarely develops following an endogenous LH surge in a setting of spontaneous multifollicular development. This has been described in case reports, particularly in women with polycystic ovarian syndrome or hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. The rarity and mildness of OHSS in this situation is due to several factors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The number of intermediate follicles present at the beginning of the LH surge",
"     </li>",
"     <li>",
"      The duration and intensity of the LH surge",
"     </li>",
"     <li>",
"      Other factors, such as inhibin, insulin-like growth factor (IGF-1), and its binding proteins",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     FSH receptor mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe, recurrent, spontaneous OHSS during pregnancy has been described in several reports. In these instances, the OHSS was due to a mutation in the serpentine region of the FSH receptor that resulted in a broadening of ligand specificity, thereby allowing stimulation by endogenous hCG [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/3,6-8\">",
"     3,6-8",
"    </a>",
"    ]. The persistent stimulation of the FSH receptor during pregnancy resulted in excessive follicular recruitment and subsequent ovarian hyperstimulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF SYSTEMIC SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Development of massive ascites and hypovolemia due to increased capillary permeability are the cardinal clinical events in the pathogenesis of OHSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/9\">",
"     9",
"    </a>",
"    ]. Hypovolemia results in hemoconcentration, decreased central venous pressure, low blood pressure, and tachycardia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Role of vascular endothelial growth factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ovarian hyperstimulation syndrome appears to be due to increased capillary permeability triggered by excessive release of one or more vasoactive substances secreted during maturation and luteinization of multiple follicles. Vascular endothelial growth factor (VEGF) of follicular origin is the main, although possibly not the only, component responsible for development of OHSS (",
"    <a class=\"graphic graphic_algorithm graphicRef82113 \" href=\"UTD.htm?31/21/32094\">",
"     algorithm 1",
"    </a>",
"    ). This peptide has two actions: it is a potent promoter of neovasculogenesis; and it may increase permeability of blood vessels walls (mediated by in part by nitric oxide), thereby disrupting functional integrity of the vascular bed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. In addition, VEGF can induce changes in cellular actin fibers, which may compromise the integrity of tight cell junctions. VEGF levels correlate with both the presence and severity of OHSS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ovarian hyperstimulation syndrome can be perceived as an exaggeration of a physiologic process. The successive stages of OHSS are [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recruitment of a large number of small antral follicles into a functional cohort",
"     </li>",
"     <li>",
"      Sustained development of numerous large antral follicles until ovulation (or luteinization)",
"     </li>",
"     <li>",
"      Excessive production of VEGF by the developing large follicles",
"     </li>",
"     <li>",
"      Exaggerated perifollicular neovascularization with some of the new blood vessels exhibiting increased permeability",
"     </li>",
"     <li>",
"      Escape of follicular fluid and perifollicular blood containing large amounts of VEGF into the peritoneal cavity and its subsequent absorption into the general vascular bed",
"     </li>",
"     <li>",
"      Functional impairment of blood vessels (not only within the ovary)",
"     </li>",
"     <li>",
"      Massive fluid shift from the intravascular to the third compartment",
"     </li>",
"     <li>",
"      Intravascular hypovolemia, concomitant with development of edema, ascites, hydrothorax",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hydropericardium.",
"     </li>",
"     <li>",
"      Impairment of cardiac, renal, pulmonary, and liver function (",
"      <a class=\"graphic graphic_algorithm graphicRef66510 \" href=\"UTD.htm?10/47/11006\">",
"       algorithm 2",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The involvement of intraovarian regulators in the pathogenesis of OHSS is likely because ovulation (luteinization) is necessary for the syndrome to occur. The concept that additional substances produced or concentrated by the hyperstimulated ovary may play a role in the development",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    progression of OHSS cannot be dismissed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/16\">",
"     16",
"    </a>",
"    ]. The exact role of interleukin-6 (IL-6), the renin-angiotensin cascade [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/17\">",
"     17",
"    </a>",
"    ], the kinin-kallikrein system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/18\">",
"     18",
"    </a>",
"    ], and selectins (cell adhesion molecules) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/19\">",
"     19",
"    </a>",
"    ], as promoters or abettors of ovarian hyperstimulation requires further study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     RENAL EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe hypovolemia is associated with decreased renal perfusion and increased reabsorption of sodium and water in the proximal tubule leading to oliguria and low urinary sodium excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/20\">",
"     20",
"    </a>",
"    ]. Exchange of hydrogen and potassium for sodium in the distal tubule is reduced, which can result in an accumulation of hydrogen and potassium ions, thereby causing hyperkalemia and a tendency to acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16660/abstract/9\">",
"     9",
"    </a>",
"    ]. Additional factors leading to increased sodium retention in patients with OHSS include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased renin production",
"     </li>",
"     <li>",
"      Enhanced aldosterone secretion",
"     </li>",
"     <li>",
"      Elevated androgens",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Severe, persistent OHSS may finally lead to impaired function of vital organs such as kidneys, lung, liver, and the cardiovascular system (",
"    <a class=\"graphic graphic_algorithm graphicRef66510 \" href=\"UTD.htm?10/47/11006\">",
"     algorithm 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24457?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of volume depletion in adults\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/1\">",
"      Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod 1997; 12:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/2\">",
"      Kaiser UB. The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 2003; 349:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/3\">",
"      Chae HD, Park EJ, Kim SH, et al. Ovarian hyperstimulation syndrome complicating a spontaneous singleton pregnancy: a case report. J Assist Reprod Genet 2001; 18:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/4\">",
"      Nappi RG, Di Naro E, D'Aries AP, Nappi L. Natural pregnancy in hypothyroid woman complicated by spontaneous ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1998; 178:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/5\">",
"      Zalel Y, Orvieto R, Ben-Rafael Z, et al. Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome. Gynecol Endocrinol 1995; 9:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/6\">",
"      Smits G, Olatunbosun O, Delbaere A, et al. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 2003; 349:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/7\">",
"      Vasseur C, Rodien P, Beau I, et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003; 349:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/8\">",
"      Montanelli L, Delbaere A, Di Carlo C, et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 2004; 89:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/9\">",
"      Engel T, Jewelewicz R, Dyrenfurth I, et al. Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment. Am J Obstet Gynecol 1972; 112:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/10\">",
"      Yan Z, Weich HA, Bernart W, et al. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab 1993; 77:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/11\">",
"      McClure N, Healy DL, Rogers PA, et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994; 344:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/12\">",
"      Shweiki D, Itin A, Neufeld G, et al. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91:2235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/13\">",
"      Levin ER, Rosen GF, Cassidenti DL, et al. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J Clin Invest 1998; 102:1978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/14\">",
"      Agrawal R, Tan SL, Wild S, et al. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 1999; 71:287.",
"     </a>",
"    </li>",
"    <li>",
"     Insler, V, Lunenfeld, B. Pathogenesis of ovarian hyperstimulation syndrome. In: In Vitro Fertilization and Assisted Reproduction, Edts. V. Gomel &amp; P.C.K. Leung, Monduzzi Editore, Bologna, 1997, pp. 433-439.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/16\">",
"      Whelan JG 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000; 73:883.",
"     </a>",
"    </li>",
"    <li>",
"     Navot, D, Bergh, PA, Palermo, R. Pathophysiology and clinical management of ovarian hyperstimulation. In: Ovulation Induction, Edts. M. Filicori &amp; C. Flamigni, Elsevier Science BV, Amsterdam, 1994, pp. 319.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/18\">",
"      Ujioka T, Matsuura K, Tanaka N, Okamura H. Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: studies in a rat model. Hum Reprod 1998; 13:3009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/19\">",
"      Daniel Y, Geva E, Amit A, et al. Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyperstimulation syndrome. Am J Reprod Immunol 2001; 45:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16660/abstract/20\">",
"      Polishuk WZ, Schenker JG. Ovarian overstimulation syndrome. Fertil Steril 1969; 20:443.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7401 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-200.215.4.194-785DB895A1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16660=[""].join("\n");
var outline_f16_17_16660=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPONTANEOUS VERSUS INDUCED OVULATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Exogenous gonadotropins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Endogenous LH surge",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      FSH receptor mutations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOGENESIS OF SYSTEMIC SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Role of vascular endothelial growth factor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      RENAL EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7401\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7401|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?31/21/32094\" title=\"algorithm 1\">",
"      Role of VEGF in OHSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?10/47/11006\" title=\"algorithm 2\">",
"      Pathogenesis of OHSS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/41/35479?source=related_link\">",
"      Classification and treatment of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24457?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of volume depletion in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13482?source=related_link\">",
"      Overview of ovulation induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=related_link\">",
"      Ovulation induction with clomiphene citrate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=related_link\">",
"      Physiology of the normal menstrual cycle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22647?source=related_link\">",
"      Prevention of ovarian hyperstimulation syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_17_16661="Venous drainage of the esophagus";
var content_f16_17_16661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F83472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F83472&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Venous drainage of the esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 694px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16661=[""].join("\n");
var outline_f16_17_16661=null;
var title_f16_17_16662="Diagnosis and management of solitary extramedullary plasmacytoma";
var content_f16_17_16662=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and management of solitary extramedullary plasmacytoma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16662/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16662/contributors\">",
"     S Vincent Rajkumar, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16662/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16662/contributors\">",
"     Robert A Kyle, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16662/contributors\">",
"     Thomas F DeLaney, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16662/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16662/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/17/16662/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma cell neoplasms (plasma cell dyscrasias) are a group of entities characterized by the neoplastic proliferation of a single clone of plasma cells, typically producing a monoclonal immunoglobulin. Plasma cell neoplasms can present as a single lesion (solitary plasmacytoma) or as multiple lesions (multiple myeloma). Solitary plasmacytomas most frequently occur in bone (plasmacytoma of bone), but can also be found outside bone in soft tissues (extramedullary plasmacytoma) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Why some patients develop multiple myeloma and others a single plasmacytoma is not understood, but might be related to differences in cellular adhesion molecules or chemokine receptor expression profiles of the malignant plasma cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Solitary extramedullary plasmacytomas (SEP, solitary extraosseous plasmacytoma) are plasma cell tumors that arise outside of the bone marrow. They are solitary lesions, and are most often located in the head and neck region, mainly in the upper aerodigestive tract, but may also occur in the gastrointestinal tract, urinary bladder, central nervous system, thyroid, breast, testes, parotid gland, lymph nodes, and skin.",
"   </p>",
"   <p>",
"    SEP refers to a solitary non-osseus plasma cell neoplasm in the absence of any other sign of multiple myeloma. The diagnosis and management of SEP will be discussed here. Note that extramedullary plasmacytomas can arise in patients with multiple myeloma at any time during the course of the disease, and should not be confused with SEP. The diagnosis and treatment of other plasma cell disorders (eg, solitary plasmacytoma of bone, multiple myeloma, primary AL amyloidosis, monoclonal gammopathy of undetermined significance) are discussed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;SEPs account for approximately 3 percent of plasma cell malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The median age at diagnosis is 55 to 60 years, and approximately two-thirds of patients are male [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients present with symptoms related to the location of the mass. Approximately 80 percent involve the upper respiratory tract (ie, oronasopharynx and paranasal sinuses), producing epistaxis, nasal discharge (rhinorrhea), or nasal obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. Less common sites of involvement include the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/12\">",
"     12",
"    </a>",
"    ], liver [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/13\">",
"     13",
"    </a>",
"    ], lymph nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], testes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/16\">",
"     16",
"    </a>",
"    ], skin, and central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/17\">",
"     17",
"    </a>",
"    ]. Primary plasmacytoma of the lung often presents as a pulmonary nodule or hilar mass with or without hemoptysis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/18\">",
"     18",
"    </a>",
"    ]. Regional lymph nodes may be involved.",
"   </p>",
"   <p>",
"    By definition, patients with SEP do not have anemia (ie, hemoglobin &lt;10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    or 2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    below normal), hypercalcemia (ie, serum calcium &gt;11.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [2.875",
"    <span class=\"nowrap\">",
"     mmol/liter]),",
"    </span>",
"    renal insufficiency (ie, serum creatinine &gt;2",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [176.8",
"    <span class=\"nowrap\">",
"     &micro;mol/liter]),",
"    </span>",
"    or bone lesions attributable to the underlying plasma cell disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient with a suspected SEP should include the following studies in addition to a complete history and physical examination:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A biopsy of the suspected lesion.",
"     </li>",
"     <li>",
"      A complete blood count and differential with examination of the peripheral blood smear.",
"     </li>",
"     <li>",
"      A chemistry screen that includes measurements of serum calcium, creatinine, albumin, lactate dehydrogenase, beta-2 microglobulin, C-reactive protein, and serum free light chains. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/23/10618?source=see_link\">",
"       \"Staging and prognostic studies in multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A serum protein electrophoresis (SPEP) with immunofixation and quantitation of immunoglobulins. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=see_link\">",
"       \"Recognition of monoclonal proteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A routine urinalysis and a 24-hour urine collection for electrophoresis (UPEP) and immunofixation. Serum free monoclonal light chain (FLC) analysis is not an adequate replacement of a 24-hour urine collection in conjunction with SPEP and immunofixation in patients with a confirmed plasma cell proliferative disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=see_link\">",
"       \"Recognition of monoclonal proteins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A unilateral bone marrow aspiration and biopsy.",
"     </li>",
"     <li>",
"      A metastatic bone survey and either a positron emission",
"      <span class=\"nowrap\">",
"       tomography/computed",
"      </span>",
"      tomography",
"      <span class=\"nowrap\">",
"       (PET/CT)",
"      </span>",
"      scan or magnetic resonance imaging (MRI) of the entire spine and pelvis. In patients with SEP not located in the head, a",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      scan is preferred over an MRI because it will detect other SEPs more frequently.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of an SEP requires the following [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/11,12,19,20\">",
"     11,12,19,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biopsy-proven extramedullary tumor with evidence of clonal plasma cells (",
"      <a class=\"graphic graphic_picture graphicRef57085 \" href=\"UTD.htm?18/58/19369\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Morphology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metastatic bone survey and either",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      or MRI of the spine and pelvis must show no lytic lesions.",
"     </li>",
"     <li>",
"      Bone marrow aspirate and biopsy must contain no clonal plasma cells. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Bone marrow examination'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is no anemia, hypercalcemia, or renal insufficiency that could be attributed to a clonal plasma cell proliferative disorder. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some patients may have a small monoclonal protein, usually IgA, in the serum or urine, which often disappears following treatment. The bone marrow of patients with SEP should have no clonal plasma cells. Some patients may demonstrate up to 10 percent clonal plasma cells, and are considered as having both SEP and monoclonal gammopathy of undetermined significance (MGUS). These patients are treated in a similar fashion to SEP, but may have a higher risk of progression to symptomatic myeloma. If patients suspected to have SEP demonstrate 10 percent or more clonal plasma cells in the bone marrow, they should be considered to have Durie-Salmon stage I myeloma rather than SEP. These patients are also often treated in a similar fashion to SEP, but may require additional systemic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to distinguish SEP from other plasma cell dyscrasias for the purposes of prognosis and treatment. The main conditions to consider in the differential diagnosis are multiple myeloma and Waldenstr&ouml;m macroglobulinemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Multiple myeloma",
"    </span>",
"    &nbsp;&mdash;&nbsp;SEP is composed of plasma cells that are histologically identical to those seen in multiple myeloma; however, the treatment of these two entities differs significantly, necessitating a careful review of the diagnosis. A distinction between these two conditions is made based upon the exclusion of additional lesions in patients with SEP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As mentioned above, the diagnosis of SEP requires the exclusion of features of multiple myeloma as evidenced by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal bone marrow with no evidence of clonal plasma cells. As noted before, occasional patients with an apparent SEP may have &lt;10 percent clonal plasma cells in the marrow. These patients are considered to have SEP plus a monoclonal gammopathy of undetermined significance (MGUS). Patients with 10 percent or more plasma cells meet the criteria for Durie-Salmon Stage I multiple myeloma.",
"     </li>",
"     <li>",
"      Skeletal survey and MRI of the spine and pelvis are negative for evidence of multiple myeloma.",
"     </li>",
"     <li>",
"      Absence of lytic lesions, anemia, hypercalcemia, and renal insufficiency, unless these are due to a cause other than a plasma cell dyscrasia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Waldenstr&ouml;m macroglobulinemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Waldenstr&ouml;m macroglobulinemia (WM) is a distinct clinicopathologic entity demonstrating lymphoplasmacytic lymphoma (LPL) in the bone marrow with an IgM monoclonal gammopathy in the blood. Patients may present with symptoms related to the infiltration of the hematopoietic tissues or the effects of monoclonal IgM in the blood. In comparison, patients with SEP will have no clonal lymphoplasmacytic cells on bone marrow biopsy and only rarely have an IgM monoclonal gammopathy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/47/762?source=see_link\">",
"     \"Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of choice for SEP is radiation therapy (RT) given with curative intent at a dose of 40 to 50 Gy over a four-week period [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. If a complete surgical resection was performed as part of the diagnosis, the role of adjuvant RT is less clear. Small lesions may be cured with surgery alone and no adjuvant RT is indicated unless there is suspicion of residual local disease. Adjuvant chemotherapy does not appear to improve relapse rate or increase disease-free survival [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/5\">",
"     5",
"    </a>",
"    ]. Bisphosphonates are not recommended for patients with SEP, except in the setting of underlying osteopenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30137?source=see_link&amp;anchor=H488867#H488867\">",
"     \"The use of bisphosphonates in patients with multiple myeloma\", section on 'Benefits of bisphosphonates in myeloma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with incompletely resected SEP, we recommend the use of local RT rather than further surgery, chemotherapy, or observation. For patients with completely resected SEP after diagnostic biopsy, we suggest observation rather than adjuvant RT or chemotherapy. This approach is based upon the following data from retrospective analyses:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A retrospective single institution analysis of 18 consecutive patients who received RT (median dose 50 Gy) for SEP of the head and neck reported no recurrences in the radiation field [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/21\">",
"       21",
"      </a>",
"      ]. There was a marginal recurrence that was treated successfully with another course of RT. At a median follow-up of 6.8 years, six patients experienced disease progression to multiple myeloma (2 patients) or developed plasmacytoma at another site (4 patients).",
"     </li>",
"     <li>",
"      A second retrospective single institution analysis of 25 consecutive patients who received RT (median dose 45 Gy) for SEP reported local recurrence in five patients (one marginal and four in-field) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/23\">",
"       23",
"      </a>",
"      ]. At a median follow-up of 64 months, the five-year probability of progression to myeloma was 30 percent and the five-year overall survival rate was 85 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ideal dose of radiation in this setting is unknown. Retrospective analyses have suggested that radiation doses of 40 Gy or greater are associated with improved local control (eg, local failure rates of 9 versus 23 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/6,21\">",
"     6,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are limited data regarding the preferred radiation volume for SEP. A retrospective study of patients with SEP of the head and neck suggested an increased risk of recurrence when RT was administered to the gross tumor plus a 2 cm margin when compared with those who received RT to the entire nasal cavity or paranasal sinuses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/21\">",
"     21",
"    </a>",
"    ]. For this reason, we prefer larger radiation fields, when toxicity permits. While there is no current evidence that treatment of adjacent lymph nodes results in improved overall response, we typically radiate adjacent nodes in those plasmacytomas with a rich lymphatic drainage with efforts to avoid irradiating any salivary glands in the process. Nodal irradiation is not given to those with a plasmacytoma in the nasal or paranasal areas, or glottis.",
"   </p>",
"   <p>",
"    As mentioned above, the role of RT after a complete surgical resection is less clear with some series suggesting improved median survival rates when adjuvant RT is used [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/8\">",
"     8",
"    </a>",
"    ] and others suggesting no difference in outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/9\">",
"     9",
"    </a>",
"    ]. Given the lack of proven benefit and potential for RT-associated complications, including radiation-induced second malignancies, we reserve adjuvant RT for patients with suspected local residual disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less than 7 percent of patients with SEP will develop a local recurrence after tumoricidal radiation; in one series all local failures were in bulky tumors &ge;5 cm in maximum diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/7\">",
"     7",
"    </a>",
"    ]. Approximately 10 to 15 percent of patients will ultimately develop multiple myeloma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/7,8,24,25\">",
"     7,8,24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reported five-year overall survival rates for patients with SEP have ranged from 40 to 85 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/9,24-26\">",
"     9,24-26",
"    </a>",
"    ]. It is unknown if tumor location affects outcome. In a series of 18 patients with SEP of the head and neck treated at the Mayo Clinic, the median overall survival was 12.5 years with 5- and 10-year survival rates of 88 and 55 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16662/abstract/21\">",
"     21",
"    </a>",
"    ]. Six patients developed multiple myeloma or plasmacytoma at a distant site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the completion of therapy, patients are seen at periodic intervals to monitor for treatment complications and assess for possible relapse. The frequency and extent of these visits depend upon the comfort of both the patient and physician. If the SEP was measurable by an imaging modality prior to therapy, the same modality (eg, MRI) should be repeated three to four months after completing therapy, and periodically thereafter.",
"   </p>",
"   <p>",
"    In general, we see patients every three months for the first two years, then every six months for an additional three years, then yearly or every other year after five years. At these visits we perform a history and physical examination, urine and serum protein electrophoresis with immunofixation, complete blood count, serum creatinine, and serum calcium. For patients with head and neck involvement, we also perform a fiberoptic endoscopy at each visit. All patients undergo",
"    <span class=\"nowrap\">",
"     CT/PET",
"    </span>",
"    or MRI (whichever imaging modality was used for the initial evaluation) every 6 to 12 months for the first five years after therapy. Other follow-up imaging depends upon the original tumor site.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solitary extramedullary plasmacytomas (SEP) are plasma cell tumors that arise outside of the bone marrow. Most patients present with symptoms related to the location of the mass, which are most frequently located in the head and neck region. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H3\">",
"     'Clinical presentation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5\">",
"     'Diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The evaluation of a patient with a suspected SEP should include a biopsy of the suspected lesion, a unilateral bone marrow aspirate and biopsy, and laboratory studies. Imaging should include a metastatic bone survey and either a positron emission",
"    <span class=\"nowrap\">",
"     tomography/computed",
"    </span>",
"    tomography",
"    <span class=\"nowrap\">",
"     (PET/CT)",
"    </span>",
"    scan or magnetic resonance imaging (MRI) of the entire spine and pelvis. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The treatment of SEP depends primarily upon whether the diagnostic biopsy was a complete or incomplete resection of the tumor:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with an incompletely resected SEP after diagnostic biopsy, we recommend the use of local radiation therapy rather than further surgery, chemotherapy, or observation (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with completely resected SEP after diagnostic biopsy, we suggest observation rather than adjuvant radiation therapy or chemotherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bisphosphonates are not recommended for patients with SEP, except in the setting of underlying osteopenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30137?source=see_link&amp;anchor=H488867#H488867\">",
"     \"The use of bisphosphonates in patients with multiple myeloma\", section on 'Benefits of bisphosphonates in myeloma'",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds), IARC Press, Lyon 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/2\">",
"      Soutar R, Lucraft H, Jackson G, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004; 124:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/3\">",
"      Hughes M, Doig A, Soutar R. Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns. Br J Haematol 2007; 137:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/4\">",
"      Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood 2000; 96:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/5\">",
"      Dores GM, Landgren O, McGlynn KA, et al. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol 2009; 144:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/6\">",
"      Shih LY, Dunn P, Leung WM, et al. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer 1995; 71:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/7\">",
"      Frassica DA, Frassica FJ, Schray MF, et al. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989; 16:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/8\">",
"      Pavithran K, Doval DC, Rao CR, et al. Pediatric solitary plasmacytoma. Acta Oncol 1997; 36:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/9\">",
"      Boos N, Goytan M, Fraser R, Aebi M. Solitary plasma-cell myeloma of the spine in an adolescent. Case report of an unusual presentation. J Bone Joint Surg Br 1997; 79:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/10\">",
"      Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer 1981; 48:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/11\">",
"      International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/12\">",
"      Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, Waldenstr&ouml;m macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc 2006; 81:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/13\">",
"      Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 1990; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/14\">",
"      Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992; 69:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/15\">",
"      Tsang RW, Gospodarowicz MK, Pintilie M, et al. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 2001; 50:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/16\">",
"      Knobel D, Zouhair A, Tsang RW, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer 2006; 6:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/17\">",
"      Bolek TW, Marcus RB Jr, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1996; 36:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/18\">",
"      Galieni P, Cavo M, Avvisati G, et al. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol 1995; 6:687.",
"     </a>",
"    </li>",
"    <li>",
"     Swerdlow SH, Campo E, Harris NL, et al. (Eds). World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/20\">",
"      Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/21\">",
"      Creach KM, Foote RL, Neben-Wittich MA, Kyle RA. Radiotherapy for extramedullary plasmacytoma of the head and neck. Int J Radiat Oncol Biol Phys 2009; 73:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/22\">",
"      Tournier-Rangeard L, Lapeyre M, Graff-Caillaud P, et al. Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control. Int J Radiat Oncol Biol Phys 2006; 64:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/23\">",
"      Reed V, Shah J, Medeiros LJ, et al. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer 2011; 117:4468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/24\">",
"      Avil&eacute;s A, Huerta-Guzm&aacute;n J, Delgado S, et al. Improved outcome in solitary bone plasmacytomata with combined therapy. Hematol Oncol 1996; 14:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/25\">",
"      Dimopoulos MA, Goldstein J, Fuller L, et al. Curability of solitary bone plasmacytoma. J Clin Oncol 1992; 10:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16662/abstract/26\">",
"      Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1983; 1:255.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6659 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-DA858D2583-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16662=[""].join("\n");
var outline_f16_17_16662=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Waldenstr&ouml;m macroglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/6659\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/6659|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/58/19369\" title=\"picture 1\">",
"      Plasmacytoma variants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/47/762?source=related_link\">",
"      Epidemiology, pathogenesis, clinical manifestations and diagnosis of Waldenstr&ouml;m macroglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/58/10154?source=related_link\">",
"      Recognition of monoclonal proteins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/23/10618?source=related_link\">",
"      Staging and prognostic studies in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30137?source=related_link\">",
"      The use of bisphosphonates in patients with multiple myeloma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_17_16663="Topical salicylic acid: Patient drug information";
var content_f16_17_16663=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Topical salicylic acid: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/23/30072?source=see_link\">",
"     see \"Topical salicylic acid: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/0/44038?source=see_link\">",
"     see \"Topical salicylic acid: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F219772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aliclen&trade;;",
"     </li>",
"     <li>",
"      Beta Sal&reg; [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Advantage&reg; Acne Cleanser [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Advantage&reg; Acne Spot Treatment [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Advantage&reg; Invisible Acne Patch [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Advantage&reg; Oil-Free Acne [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Blackhead Clearing Daily Cleansing [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Blackhead Clearing Scrub [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Deep Cleaning [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Dual Action Moisturizer [OTC];",
"     </li>",
"     <li>",
"      Clean &amp; Clear&reg; Invisible Blemish Treatment [OTC];",
"     </li>",
"     <li>",
"      Compound W&reg; One Step Invisible Strip [OTC];",
"     </li>",
"     <li>",
"      Compound W&reg; One Step Wart Remover for Feet [OTC];",
"     </li>",
"     <li>",
"      Compound W&reg; One-Step Wart Remover for Kids [OTC];",
"     </li>",
"     <li>",
"      Compound W&reg; One-Step Wart Remover [OTC];",
"     </li>",
"     <li>",
"      Compound W&reg; [OTC];",
"     </li>",
"     <li>",
"      Curad&reg; Mediplast&reg; [OTC];",
"     </li>",
"     <li>",
"      Denorex&reg; Extra Strength Protection 2-in-1 [OTC];",
"     </li>",
"     <li>",
"      Denorex&reg; Extra Strength Protection [OTC];",
"     </li>",
"     <li>",
"      Dermarest&reg; Psoriasis Medicated Moisturizer [OTC];",
"     </li>",
"     <li>",
"      Dermarest&reg; Psoriasis Medicated Scalp Treatment [OTC];",
"     </li>",
"     <li>",
"      Dermarest&reg; Psoriasis Medicated Shampoo/Conditioner [OTC];",
"     </li>",
"     <li>",
"      Dermarest&reg; Psoriasis Medicated Skin Treatment [OTC];",
"     </li>",
"     <li>",
"      Dermarest&reg; Psoriasis Overnight Treatment [OTC];",
"     </li>",
"     <li>",
"      DHS&trade; Sal [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Callus Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Clear Away&reg; One Step Wart Remover [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Clear Away&reg; Plantar Wart Remover For Feet [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Clear Away&reg; Wart Remover Fast-Acting [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Clear Away&reg; Wart Remover Invisible Strips [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Clear Away&reg; Wart Remover [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Corn Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Corn/Callus Remover [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Extra Thick Corn Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Extra-Thick Callus Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; For Her Corn Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; OneStep Callus Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; OneStep Corn Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Small Corn Removers [OTC];",
"     </li>",
"     <li>",
"      Dr. Scholl's&reg; Ultra-Thin Corn Removers [OTC];",
"     </li>",
"     <li>",
"      DuoFilm&reg; [OTC];",
"     </li>",
"     <li>",
"      Freezone&reg; [OTC];",
"     </li>",
"     <li>",
"      Fung-O&reg; [OTC];",
"     </li>",
"     <li>",
"      Gets-It&reg; [OTC];",
"     </li>",
"     <li>",
"      Gordofilm [OTC];",
"     </li>",
"     <li>",
"      Hydrisalic&reg; [OTC];",
"     </li>",
"     <li>",
"      Ionil Plus&reg; [OTC];",
"     </li>",
"     <li>",
"      Ionil&reg; [OTC];",
"     </li>",
"     <li>",
"      Keralyt&reg;;",
"     </li>",
"     <li>",
"      Keralyt&reg; [OTC];",
"     </li>",
"     <li>",
"      LupiCare&reg; Dandruff [OTC];",
"     </li>",
"     <li>",
"      LupiCare&reg; Psoriasis [OTC];",
"     </li>",
"     <li>",
"      MG217&reg; Sal-Acid [OTC];",
"     </li>",
"     <li>",
"      Mosco&reg; Callus &amp; Corn Remover [OTC];",
"     </li>",
"     <li>",
"      Mosco&reg; One Step Corn Remover [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Acne Stress Control [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Advanced Solutions&trade; [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Blackhead Eliminating&trade; 2-in-1 Foaming Pads [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Blackhead Eliminating&trade; Daily Scrub [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Blackhead Eliminating&trade; [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Body Clear&reg; [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Clear Pore&trade; Oil-Controlling Astringent [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Maximum Strength T/Sal&reg; [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Acne Stress Control [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Acne Wash 60 Second Mask Scrub [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Acne Wash Cream Cleanser [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Acne Wash Foam Cleanser [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Acne Wash [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Acne [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Oil-Free Anti-Acne [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Rapid Clear&reg; Acne Defense [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Rapid Clear&reg; Acne Eliminating [OTC];",
"     </li>",
"     <li>",
"      Neutrogena&reg; Rapid Clear&reg; [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Body Wash [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Chill Factor&reg; [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Daily Cleansing [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Daily [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Face Wash [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Maximum Daily Cleansing [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Maximum [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Post-Shave [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; Spot Treatment [OTC];",
"     </li>",
"     <li>",
"      OXY&reg; [OTC];",
"     </li>",
"     <li>",
"      P&amp;S&reg; [OTC];",
"     </li>",
"     <li>",
"      Palmer's&reg; Skin Success Acne Cleanser [OTC];",
"     </li>",
"     <li>",
"      Sal-Plant&reg; [OTC];",
"     </li>",
"     <li>",
"      Salactic&reg; [OTC];",
"     </li>",
"     <li>",
"      Salex&reg;;",
"     </li>",
"     <li>",
"      Salvax;",
"     </li>",
"     <li>",
"      Scalpicin&reg; Anti-Itch [OTC];",
"     </li>",
"     <li>",
"      Selsun blue&reg; Deep Cleaning Micro-Bead Scrub [OTC];",
"     </li>",
"     <li>",
"      Selsun blue&reg; Naturals Island Breeze [OTC];",
"     </li>",
"     <li>",
"      Selsun blue&reg; Naturals Itchy Dry Scalp [OTC];",
"     </li>",
"     <li>",
"      Stridex&reg; Essential Care&reg; [OTC];",
"     </li>",
"     <li>",
"      Stridex&reg; Facewipes To Go&reg; [OTC];",
"     </li>",
"     <li>",
"      Stridex&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Stridex&reg; Sensitive Skin [OTC];",
"     </li>",
"     <li>",
"      Thera-Sal [OTC] [DSC];",
"     </li>",
"     <li>",
"      Tinamed&reg; Corn and Callus Remover [OTC];",
"     </li>",
"     <li>",
"      Tinamed&reg; Wart Remover [OTC];",
"     </li>",
"     <li>",
"      Trans-Ver-Sal&reg; [OTC];",
"     </li>",
"     <li>",
"      Virasal&reg;;",
"     </li>",
"     <li>",
"      Wart-Off&reg; Maximum Strength [OTC];",
"     </li>",
"     <li>",
"      Zapzyt&reg; Acne Wash [OTC];",
"     </li>",
"     <li>",
"      Zapzyt&reg; Pore Treatment [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F219773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Duofilm&reg;;",
"     </li>",
"     <li>",
"      Duoforte&reg; 27;",
"     </li>",
"     <li>",
"      Occlusal&trade;-HP;",
"     </li>",
"     <li>",
"      Sebcur&reg;;",
"     </li>",
"     <li>",
"      Soluver&reg;;",
"     </li>",
"     <li>",
"      Soluver&reg; Plus;",
"     </li>",
"     <li>",
"      Trans-Plantar&reg;;",
"     </li>",
"     <li>",
"      Trans-Ver-Sal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691803",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat dandruff.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to get rid of calluses, corns, and warts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat psoriasis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to control seborrheic dermatitis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to salicylic acid or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697194",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have chickenpox or the flu, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The patch may have metal. Take off the patch before an MRI.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698017",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698301",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Peeling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699056",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ringing in ears.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705318",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Pimples (acne):",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Creme, cloth, foam, or liquid cleanser:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use on clean affected skin 1 or 2 times each day or as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected part and work into a lather and rinse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wet cloth with water before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705530",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shower/bath gels or soap:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696218",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use to clean every day in the shower or bath.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696278",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Work into a lather and rinse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Gel, pad, or patch:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696237",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash affected skin and pat dry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Let skin dry for 5 minutes before putting on patch.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694471",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put patch on the affected skin before bedtime.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695575",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take off patch in the morning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694427",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer of gel on the affected part and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use pad to put on a thin layer of salicylic acid to affected part.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not leave pad on skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695135",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If peeling happens, lower the number of times the drug is used.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694417",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use 1 to 4 times every day or as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705341",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Callus, corns, or warts:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696237",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash affected skin and pat dry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695357",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may soak the affected part for 5 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake foam well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694456",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put foam on affected part and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694459",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put gel or liquid on affected part and let dry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trim patch to cover the affected skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694192",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       40% patches are used once every other day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take off patch (15%) or rinse off gel in the morning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695356",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may repeat 1 or 2 times a day or as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705369",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Dandruff, psoriasis, or seborrheic dermatitis:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some products may be left in place overnight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705365",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cream, ointment:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694500",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on clean, dry skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on up to 4 times a day or as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694680",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put ointment on the face or scalp.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705526",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shampoo:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696268",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wet hair before shampoo.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Work into hair or affected skin gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Leave on hair for a few minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695595",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse fully.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694418",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on 2 to 3 times a week or as you have been told by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12113 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16663=[""].join("\n");
var outline_f16_17_16663=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219772\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F219773\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022721\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022720\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022725\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022726\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022728\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022723\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022724\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022729\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022730\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?29/23/30072?source=related_link\">",
"      Topical salicylic acid: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/0/44038?source=related_link\">",
"      Topical salicylic acid: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_17_16664="Surgical treatment of erectile dysfunction";
var content_f16_17_16664=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical treatment of erectile dysfunction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16664/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16664/contributors\">",
"     Stephen Lazarou, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16664/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16664/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/17/16664/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/17/16664/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/17/16664/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erectile dysfunction (ED) affects approximately 40 to 50 million American men each year. The introduction of phosphodiesterase inhibitors, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    , has revolutionized the care of these patients, but surgery still has a clear role when these inhibitors and other approaches fail or are contraindicated.",
"   </p>",
"   <p>",
"    The surgical management of erectile dysfunction, including implantation of penile prostheses and penile vascular (arterial and venous) reconstruction are reviewed here. The correction of curvature abnormalities (ie, Peyronie's disease) and other aspects of erectile dysfunction are discussed elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=see_link\">",
"       \"Overview of male sexual dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=see_link\">",
"       \"Evaluation of male sexual dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=see_link\">",
"       \"Treatment of male sexual dysfunction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42007?source=see_link\">",
"       \"Surgical management of Peyronie's disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical management of erectile dysfunction should be reserved for men who cannot use, or who have not responded to, first and second-line therapies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=see_link&amp;anchor=H2#H2\">",
"     \"Treatment of male sexual dysfunction\", section on 'General principles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with curvature abnormalities (ie, Peyronie's disease) with ED or significant risk factors for future ED, are candidates for the placement of a penile prosthesis at the time of their reconstructive surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Implantation of a penile prosthesis is contraindicated in the presence of infection (eg, systemic, pulmonary, urinary tract, cutaneous). The penis and scrotum must be free of any dermatitis, wounds, or other cutaneous lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough review of the patient's medical and surgical history, and physical examination including a complete urologic examination are performed. History and physical examination are directed at evaluating the efficacy of previous nonsurgical treatments, identifying medical risk factors or other conditions (eg, infection) that may contraindicate the procedure, and confirming the presence and nature of erectile dysfunction.",
"   </p>",
"   <p>",
"    The patient's manual dexterity must be considered when choosing the type of penile implant. If the patient cannot operate his device, he must have a willing and able partner who can assist him. Semirigid devices generally require less manual dexterity to operate.",
"   </p>",
"   <p>",
"    The author performs a penile duplex ultrasound study following intracorporeal injection of a vasodilating agent to assess tumescence and vascular flow prior to placement of a penile prosthesis. This study assesses the tumescence, length, and girth of the penis, which help guide the choice of implant. The presence of vascular insufficiency can also be determined.",
"   </p>",
"   <p>",
"    For men who are potential candidates for penile revascularization, a preoperative pelvic and penile arteriogram is necessary to determine the location and severity of vascular obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=see_link\">",
"     \"Evaluation of male sexual dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Medical risk evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most men with erectile dysfunction not due to sequelae of trauma will have been screened for cardiovascular disease or diabetes prior to institution of medical therapy. Repeat evaluation may be needed prior to surgery since erectile dysfunction is a marker of cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=see_link\">",
"     \"Evaluation of male sexual dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Men with significant cardiovascular disease are not good candidates for penile revascularization; however, if their cardiac risk is not high, they may be a candidate for a penile implant. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Penile prostheses'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19\">",
"     'Penile revascularization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Diabetes mellitus is associated with a higher risk of perioperative infection. While improving control of diabetes mellitus before surgery has reduced the risk of infection for some surgeries, a consistent benefit for patients undergoing penile implants has not been found [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29688?source=see_link\">",
"     \"Perioperative management of diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should avoid taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and nonsteroidal anti-inflammatory medications for seven days prior to the procedure, as these may increase the risk of postoperative bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=see_link&amp;anchor=H25#H25\">",
"     \"Perioperative medication management\", section on 'Medications affecting hemostasis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Antimicrobial prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic prophylaxis with activity against flora of the skin and genitourinary tract should be administered within one hour of incision [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/9\">",
"     9",
"    </a>",
"    ]. Reasonable choices for skin organisms include a cephalosporin (first or second generation) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    ; reasonable choices for urinary tract organisms include a fluoroquinolone, aminoglycoside or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/25/43414?source=see_link\">",
"     aztreonam",
"    </a>",
"    . While the American Urologic Association guidelines suggest that prophylaxis should be discontinued within 24 hours of the procedure, these guidelines are not specific to the placement of prostheses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/9\">",
"     9",
"    </a>",
"    ]. As such, we continue antibiotics for one week following placement of penile protheses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H22#H22\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Genitourinary surgery'",
"    </a>",
"    .)&nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Patient counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough preoperative discussion is essential, and should review preparation, complications and outcomes of surgery.",
"   </p>",
"   <p>",
"    The patient considering prosthesis implantation should be informed of the potential complications which include wound infection, urethral injury, penile shortening, impaired sensation, mechanical failure (ie, inflatable implants) or the potential need for reoperation due to implant erosion or infection. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Implant complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The penis is composed of three cylindrical masses (two corpora cavernosa, corpora spongiosum) bounded by fibrous tissue and covered with skin (",
"    <a class=\"graphic graphic_figure graphicRef66964 \" href=\"UTD.htm?11/3/11319\">",
"     figure 1",
"    </a>",
"    ). The tunica surrounds the corpora cavernosa and is composed of collagen arranged in circular and longitudinal layers. The inner circumferential layer contains intracavernosal pillars that help tether the corporal bodies limiting overexpansion. The outer longitudinal collagen fibers run from the glans penis to the proximal crura at the base of the penis.",
"   </p>",
"   <p>",
"    The main arterial vascular supply is derived from the internal pudendal artery, which is a branch of the internal iliac artery. The internal pudendal becomes the common penile artery, which branches into the dorsal, bulbourethral, and cavernous arteries. The cavernous or cavernosal artery supplies the helicine arterioles supplying the spongy trabecular tissues that store and trap blood during an erection.",
"   </p>",
"   <p>",
"    The cavernosal tissue is drained by venules that coalesce to form subtunical venules before exiting the tunica albuginea as emissary veins. The emissary veins run obliquely between the inner and outer layers of the tunica. These veins drain the corporal bodies; a septum between the corporal bodies allows vascular communication between them. The emissary veins unite, forming the circumflex, periurethral, and superficial dorsal veins.",
"   </p>",
"   <p>",
"    Erectile physiology is discussed in detail elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=see_link&amp;anchor=H2095227#H2095227\">",
"     \"Overview of male sexual dysfunction\", section on 'Physiology of male sexual function'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PENILE PROSTHESES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penile prostheses have been used for the treatment of erectile dysfunction since the 1950s. The first implants consisted of rib cartilage, modeled after the os penis of some animals. Subcutaneous acrylic splints, polyethylene rods, and pure silicone implants were used in the past. A major advance in prosthetic surgery has been the placement of devices within the paired corpora cavernosa, providing improved cosmetic and functional results [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/10-14\">",
"     10-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early inflatable prosthetic models were plagued by mechanical dysfunction, aneurysm formation, and S-shaped deformities [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/15\">",
"     15",
"    </a>",
"    ]. Over time, inflatable devices have become more dependable with high rates of patient satisfaction. Following the introduction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/19/33080?source=see_link\">",
"     sildenafil",
"    </a>",
"    in 1998, the use of penile prostheses dropped considerably. However, the subsequent development of tolerance to medical therapy led to a rebound in the number of implanted penile prostheses that exceeded pre-1998 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/16\">",
"     16",
"    </a>",
"    ]. Two types of penile implants are commercially available; inflatable prosthetics accounting for the majority of implants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Types",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Semi-rigid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Semi-rigid rods have been available for several decades. They are easy to use but result in a permanent erection (",
"    <a class=\"graphic graphic_picture graphicRef81251 \" href=\"UTD.htm?29/6/29796\">",
"     picture 1",
"    </a>",
"    ). Although semi-rigid devices continue to be used successfully, they make up less than 10 percent of all implanted penile prostheses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mechanical reliability of malleable devices is excellent, and they are easy to implant via subcoronal, penoscrotal, or infrapubic incisions. Because they are malleable, the penis can be bent down close to the body to be less noticeable under clothing. Malleable prostheses bend with relative ease, but they may have some spring-back. This means that they have some \"memory\" as to their original shape, and will return to some degree to their original straight position. The degree of spring-back determines the level of conceal ability for the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Inflatable",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inflatable prostheses are designed to approximate the rigidity and flaccidity of the normally functioning penis. These devices consist of two hollow cylinders placed within the corpora cavernosa, a saline reservoir and pump (",
"    <a class=\"graphic graphic_figure graphicRef54550 \" href=\"UTD.htm?5/52/5952\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/19\">",
"     19",
"    </a>",
"    ]. Designs and materials for inflatable penile prostheses have continued to improve over time with high rates of patient satisfaction (&gt;90 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/17,20-29\">",
"     17,20-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inflatable prostheses are generally available in two- or three-piece designs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two-piece &mdash; Two-piece penile prostheses are comprised of intracavernosal cylinders attached to a small scrotal pump (",
"      <a class=\"graphic graphic_picture graphicRef79647 \" href=\"UTD.htm?32/33/33298\">",
"       picture 2",
"      </a>",
"      ). Inflation of the device is achieved by squeezing the pump, which redistributes saline from a reservoir in the rear of the cylinders to the front of the cylinders, creating rigidity in the outward aspect of the corpora cavernosa, thus creating an erection. Deflation is accomplished by bending the cylinders (and the penis), which activates a valve allowing fluid to return to the reservoir area. In the flaccid state, the two-piece prosthesis appears fuller than a multicomponent device, because less fluid is transferred to the smaller reservoir area.",
"      <br/>",
"      <br/>",
"      The main advantage of the two-piece prosthesis is simplified operative placement because of the integrated reservoir (ie, no need to fill or need to connect). The two-piece implant is particularly useful when prior pelvic or inguinal surgery prevent the placement of a separate reservoir. Another advantage is the ease of deflation, which requires less dexterity and digital sensitivity than multicomponent devices [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/13\">",
"       13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Patient satisfaction has been shown to be as high as 96 percent and mechanical failure rates less than 5 percent over a five-year period [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/13,20\">",
"       13,20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Three-piece &mdash; The three-piece implant consists of penile cylinders, a scrotal pump, and retropubic reservoir (",
"      <a class=\"graphic graphic_picture graphicRef71063 \" href=\"UTD.htm?37/21/38239\">",
"       picture 3",
"      </a>",
"      ). Erection is achieved by repeatedly squeezing the pump; each compression transfers fluid from the reservoir to the intracorporeal cylinders until adequate rigidity is achieved (",
"      <a class=\"graphic graphic_figure graphicRef54550 \" href=\"UTD.htm?5/52/5952\">",
"       figure 2",
"      </a>",
"      ). Pressing a valve mechanism in the scrotal pump causes fluid to flow from of the cylinders back to the reservoir.",
"     </li>",
"     <li>",
"      Variations &mdash; Special designs provide increased length in addition to width and rear tip extenders can be added to the back of the cylinders to modify length further. Other designs are available to accommodate fibrotic corpora or the shortened penis. Some penile prostheses have smaller reservoirs; others have a lockout valve to prevent cylinder autoinflation (ie, fluid unintentionally transferred from reservoir to cylinders) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/23,30\">",
"       23,30",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Autoinflation is typically due to compression on the reservoir (ie, abdominal straining) and causes partial unintended erections, which may be socially awkward. By preventing autoinflation, the lockout valve also permits the surgeon to place the reservoir in sites prone to the effects of increased abdominal pressure, such as an epigastric, subcutaneous, or subrectus location.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Antimicrobial coated implants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotic-coatings provide an effective way to reduce the risk of perioperative infection, and are available with some inflatable prostheses. InhibiZone&reg; is an FDA-approved surface treatment of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/27,31\">",
"     27,31",
"    </a>",
"    ]. Resist&trade; combines an antibiotic solution of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/20/6469?source=see_link\">",
"     bacitracin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/32\">",
"     32",
"    </a>",
"    ]. These coatings are impregnated onto the external silicone surfaces of the implanted components. Another approach coats the implant with a hydrophilic coating that reduces bacterial adherence, and absorbs antibiotics when the implant is immersed in antibiotic-containing solution [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several retrospective studies have reported significant reductions in infection rates with antibiotic-treated implants compared with non-treated implants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/31,32,34\">",
"     31,32,34",
"    </a>",
"    ]. However, there are no randomized trials comparing the various antimicrobial implants to suggest the superiority of one over another.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Choice of implant",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, the choice of prosthesis type is a personal one based upon the patient's preference and perception of function and cosmesis. As a general rule, most men prefer the more natural capabilities of inflatable prostheses.",
"   </p>",
"   <p>",
"    Other factors may be important in specialized populations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Older men, especially those with limited mental or manual dexterity, should be offered a semi-rigid implant because manipulating the pump and deflation mechanisms of inflatable devices may be challenging.",
"     </li>",
"     <li>",
"      Patients with diminished sensation in the penis (ie, spinal cord injury), should be offered an inflatable device to decrease the potential for skin or urethral erosion due to prolonged excessive pressure on the rods [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;The placement of penile prostheses is usually performed as an outpatient procedure under general, spinal, or epidural anesthesia, but it can be also be performed with local anesthesia and monitored sedation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Following the procedure, the patient is instructed not to use the device for four to six weeks to ensure adequate healing.",
"   </p>",
"   <p>",
"    Placement of these devices can be performed through a penoscrotal, infrapubic, or subcoronal approach. The operative area is shaved immediately prior to surgery and the skin prepared. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'General principles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Corporotomies are made in the corpora cavernosa, which are then dilated and measured. The appropriate-sized device is chosen, both in terms of length and diameter. The pump is placed in the scrotum. If a three-piece device is chosen, the reservoir is placed preperitoneally behind the rectus muscle, either through the external inguinal ring or via a separate lower abdominal incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Considerations for Peyronie's disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Either a two- or three-piece prostheses can be used in the management of Peyronie's disease. For men with significant plaques and curvature, a \"modeling\" procedure may be performed in which the tunical plaque is fractured over an inflated cylinder at the time of implantation. In this procedure, the penis is forcibly bent in a direction opposite the curvature [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/39\">",
"     39",
"    </a>",
"    ]. Bending pressure is maintained on the penis for 90 seconds. When successful, the modeling procedure results in splitting and rupturing of the fibrotic plaques.",
"   </p>",
"   <p>",
"    If the plaque is not able to be fractured, then a combination of plaque incision and grafting may be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42007?source=see_link&amp;anchor=H14#H14\">",
"     \"Surgical management of Peyronie's disease\", section on 'Grafting'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Implant complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most serious complication of penile prosthesis implantation is infection; however, mechanical failure can also occur with surgical revision required in 5 to 15 percent of men over one to seven years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/18,20-22,40\">",
"     18,20-22,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Implant infection occurs in approximately 3 percent of cases; patients with diabetes, spinal cord injury, or previous implants have infection rates up to 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/5,6,41\">",
"     5,6,41",
"    </a>",
"    ]. Infection usually occurs within three months of implantation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most implant infections occur as a result of intraoperative contamination with normal skin flora such as Staphylococcus epidermidis; these organisms have been isolated from 30 to 50 percent of infected prostheses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/5,43,44\">",
"     5,43,44",
"    </a>",
"    ]. Aerobic gram-negative organisms, such as Proteus, Pseudomonas, E. coli and Serratia, also cause implant infections. Rarely, cases of infection due to Candida albicans, mycobacteria and gonococci can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/42,45,46\">",
"     42,45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of implant infections can be reduced with meticulous attention to sterile technique, and delay of implantation until after adequate treatment of any known infections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/47\">",
"     47",
"    </a>",
"    ]. Antibiotic-coated prostheses may also be useful for prevention of infection in some circumstances. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Antimicrobial coated implants'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Clinical manifestations include penile pain, erythema, and induration over the prosthesis or device extrusion. Subclinical infections manifest most commonly with chronic penile pain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of suspected infection usually requires surgical exploration. Early culture, debridement and irrigation facilitate microbiological diagnosis, and may reduce the likelihood that a biofilm will form on the implants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/49-51\">",
"     49-51",
"    </a>",
"    ]. Material from the wound should be sent for gram stain and culture with sensitivity. If the wound gram stain is negative (ie, no organisms, no white cells), the site should be thoroughly irrigated, the prosthesis can be left in place and the wound closed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/41,50\">",
"     41,50",
"    </a>",
"    ]. The presence of frank purulence usually necessitates removal of the entire device and vigorous wound irrigation.",
"   </p>",
"   <p>",
"    Empiric therapy prior to the return of culture results should cover both gram-positive skin flora and aerobic enteric bacterial flora (eg, E coli, Klebsiella spp.). Appropriate empiric regimens include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (1 g IV) with dosing adjusted for appropriate blood levels, and either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    (1 g IV daily) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    (400 mg IV every 12 hours or 500 to 750 mg orally twice daily). Antibiotic selection should be tailored to culture and sensitivity results when available.",
"   </p>",
"   <p>",
"    The duration of therapy depends on individual circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For eradication of infection following implant removal, 7 to 14 days of therapy is usually effective. Reimplantation of a new prosthesis can be considered a minimum of three months after treatment is completed if there are no ongoing signs of infection [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      For implant salvage, the duration of therapy depends upon the clinical response to therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/41\">",
"       41",
"      </a>",
"      ]. Treatment with parenteral therapy is indicated until signs of infection have resolved, and many clinicians transition to oral antibiotics; the duration of oral treatment depends on the clinical scenario. In these cases, it is important to have a definitive microbiological diagnosis to guide decisions about route and duration of treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PENILE REVASCULARIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly performed technique for penile revascularization involves anastomosis of the inferior epigastric artery to the dorsal penile artery (dorsal artery arterialization). The original technique, which is less often performed, uses the dorsal penile vein as the distal target (dorsal vein arterialization).",
"   </p>",
"   <p>",
"    Arterial revascularization relies on the inferior epigastric artery. A paramedian abdominal incision is made, and the inferior epigastric vessels dissected from the lower surface of the rectus muscle. The inferior epigastric artery is then anastomosed to the deep penile artery (Hauri technique) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Penile dorsal artery arterialization requires microsurgical skill and is generally performed in specialized centers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/47,53-56\">",
"     47,53-56",
"    </a>",
"    ]. An analysis of 25 trials identified risk factors associated with failure of penile revascularization, including smoking, diabetes mellitus, hypertension, hyperlipidemia, history of radiation therapy, coronary artery disease, alcohol abuse, obesity, cavernosal fibrosis, and distal arterial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postoperative complications may include penile edema, penile numbness, and penile shortening due to scar entrapment.",
"   </p>",
"   <p>",
"    Reasonable success rates for penile revascularization are achieved in young, nonsmoking, otherwise healthy men who have recently acquired erectile dysfunction due to a focal arterial occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/53,54,57-63\">",
"     53,54,57-63",
"    </a>",
"    ]. Only 6 to 7 percent of men with vascular erectile dysfunction are candidates for penile revascularization with these restricted criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/47\">",
"     47",
"    </a>",
"    ]. Long-term success rates range from 50 to 67 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/53,54,60,63\">",
"     53,54,60,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Techniques to improve the veno-occlusive mechanism with ligation of the dorsal, cavernous, and crural veins were popular toward the end of the 20th century due to encouraging early results; however, efficacy beyond six months was minimal and these procedures have been largely abandoned in favor of medical therapies with phosphodiesterase-5 (PDE-5) inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/56,58\">",
"     56,58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In summary, several surgical procedures may help men with erectile dysfunction who do not respond to pharmacologic therapy, and for select patients with Peyronie's disease. The cause of the erectile dysfunction and the general health of the individual should determine the type of procedure. Our recommendations are consistent with clinical guidelines published by the American Urological Association [",
"    <a class=\"abstract\" href=\"UTD.htm?16/17/16664/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Penile implants",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Penile prosthesis implantation has the highest satisfaction rates of all treatment options, including pharmacologic therapy, for erectile dysfunction. Prostheses have allowed men to have effective, reliable, and cosmetically acceptable erections, as well as an acceptable appearance when flaccid. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Penile prostheses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most cases, the choice regarding the type of prosthesis is made on the basis of cosmesis and function. As a rule, men prefer the capability of inflatable prostheses to mimic the normal penis, both for its usual state of flaccidity, and for its ability to become rigid for sexual activity. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Inflatable'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast, older men, especially those with limited mental or manual dexterity, may prefer a semi-rigid rod, since it may be challenging to manipulate the pump and deflation mechanisms of the inflatable devices. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Semi-rigid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Penile implant infection is the most serious complication of penile implants, and most often requires complete removal of the device and intravenous antibiotic therapy. Penile implant salvage can be considered in select cases. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Infection'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Penile revascularization",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For most men with vascular erectile dysfunction, we suggest avoiding penile arterial revascularization given the low success rates, and long-term complications (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Penile revascularization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Penile arterial revascularization (performed at a specialty center) may be reasonable for young, nonsmoking, otherwise healthy men without evidence of generalized vascular disease, diabetes, or hypertension, who have recently acquired erectile dysfunction secondary to a focal arterial occlusion (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Penile revascularization'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      For men with erectile dysfunction with veno-occlusive disease, we suggest not performing penile venous surgery given the low success rates, and the availability of effective oral medications such as phosphodiesterase-5 (PDE-5) inhibitors (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Penile revascularization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/1\">",
"      Batty GD, Li Q, Czernichow S, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol 2010; 56:1908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/2\">",
"      Jackson G, Montorsi P, Adams MA, et al. Cardiovascular aspects of sexual medicine. J Sex Med 2010; 7:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/3\">",
"      Schwartz BG, Kloner RA. Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation 2011; 123:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/4\">",
"      Shin D, Pregenzer G Jr, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev 2011; 19:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/5\">",
"      Jarow JP. Risk factors for penile prosthetic infection. J Urol 1996; 156:402.",
"     </a>",
"    </li>",
"    <li>",
"     Lewis, RW, McLaren, R. Reoperation for penile prosthesis implantation. Probl Urol 1993; 7:381. (DOI: 10.1159/000067984) .",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/7\">",
"      Wilson SK, Carson CC, Cleves MA, Delk JR 2nd. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol 1998; 159:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/8\">",
"      Bishop JR, Moul JW, Sihelnik SA, et al. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol 1992; 147:386.",
"     </a>",
"    </li>",
"    <li>",
"     Wolf, JS, Bennett, CJ, Dmochowski, RR et al. The best practice policy statement of urologic surgery antimicrobial prophylaxis. American Urological Association, 2008. auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/antimicroprop08.pdf (Accessed on February 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/10\">",
"      Lue TF. Erectile dysfunction. N Engl J Med 2000; 342:1802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/11\">",
"      Morgentaler A. Male impotence. Lancet 1999; 354:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/12\">",
"      Montague DK, Angermeier KW. Penile prosthesis implantation. Urol Clin North Am 2001; 28:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/13\">",
"      Khoudary KP, Morgentaler A. Design considerations in penile prostheses: the American Medical Systems product line. J Long Term Eff Med Implants 1997; 7:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/14\">",
"      Scott FB, Bradley WE, Timm GW. Management of erectile impotence. Use of implantable inflatable prosthesis. Urology 1973; 2:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/15\">",
"      Wilson SK, Cleves MA, Delk JR 2nd. Ultrex cylinders: problems with uncontrolled lengthening (the S-shaped deformity). J Urol 1996; 155:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/16\">",
"      Henry GD, Wilson SK. Updates in inflatable penile prostheses. Urol Clin North Am 2007; 34:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/17\">",
"      Lightfoot AJ, Rosevear HM, Kreder KJ. Inflatable penile prostheses: an update. Curr Opin Urol 2010; 20:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/18\">",
"      Wilson, SK. Penile prostheses at the millennium. Contemporary Urology 2001; 13:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/19\">",
"      Quesada ET, Light JK. The AMS 700 inflatable penile prosthesis: long-term experience with the controlled expansion cylinders. J Urol 1993; 149:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/20\">",
"      Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol 2001; 166:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/21\">",
"      Garber BB. Mentor Alpha 1 inflatable penile prosthesis: patient satisfaction and device reliability. Urology 1994; 43:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/22\">",
"      Carson CC, Mulcahy JJ, Govier FE. Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. AMS 700CX Study Group. J Urol 2000; 164:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/23\">",
"      Wilson SK, Henry GD, Delk JR Jr, Cleves MA. The mentor Alpha 1 penile prosthesis with reservoir lock-out valve: effective prevention of auto-inflation with improved capability for ectopic reservoir placement. J Urol 2002; 168:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/24\">",
"      Knoll LD, Henry G, Culkin D, et al. Physician and patient satisfaction with the new AMS 700 momentary squeeze inflatable penile prosthesis. J Sex Med 2009; 6:1773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/25\">",
"      Salem EA, Wilson SK, Neeb A, et al. Mechanical reliability of AMS 700 CX improved by parylene coating. J Sex Med 2009; 6:2615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/26\">",
"      Henry GD, Kansal NS, Callaway M, et al. Centers of excellence concept and penile prostheses: an outcome analysis. J Urol 2009; 181:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/27\">",
"      McKim SE, Carson CC 3rd. AMS 700 inflatable penile prosthesis with InhibiZone. Expert Rev Med Devices 2010; 7:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/28\">",
"      Wilson SK, Delk JR, Salem EA, Cleves MA. Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades. J Sex Med 2007; 4:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/29\">",
"      Bettocchi C, Palumbo F, Spilotros M, et al. Patient and partner satisfaction after AMS inflatable penile prosthesis implant. J Sex Med 2010; 7:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/30\">",
"      Hollenbeck BK, Miller DC, Ohl DA. The utility of lockout valve reservoirs in preventing autoinflation in penile prostheses. Int Urol Nephrol 2002; 34:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/31\">",
"      Carson CC 3rd. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004; 171:1611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/32\">",
"      Hellstrom WJ, Hyun JS, Human L, et al. Antimicrobial activity of antibiotic-soaked, Resist-coated Bioflex. Int J Impot Res 2003; 15:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/33\">",
"      Wolter CE, Hellstrom WJ. The hydrophilic-coated inflatable penile prosthesis: 1-year experience. J Sex Med 2004; 1:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/34\">",
"      Wilson SK, Zumbe J, Henry GD, et al. Infection reduction using antibiotic-coated inflatable penile prosthesis. Urology 2007; 70:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/35\">",
"      Cakan M, Demirel F, Karabacak O, et al. Risk factors for penile prosthetic infection. Int Urol Nephrol 2003; 35:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/36\">",
"      Gross AJ, Sauerwein DH, Kutzenberger J, Ringert RH. Penile prostheses in paraplegic men. Br J Urol 1996; 78:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/37\">",
"      Dos Reis JM, Glina S, Da Silva MF, Furlan V. Penile prosthesis surgery with the patient under local regional anesthesia. J Urol 1993; 150:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/38\">",
"      Kaufman JJ. Penile prosthetic surgery under local anesthesia. J Urol 1982; 128:1190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/39\">",
"      Wilson SK, Cleves MA, Delk JR 2nd. Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 2001; 165:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/40\">",
"      Furlow WL, Goldwasser B, Gundian JC. Implantation of model AMS 700 penile prosthesis: long-term results. J Urol 1988; 139:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/41\">",
"      Wilson SK, Delk JR 2nd. Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 1995; 153:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/42\">",
"      Fishman, IJ, Scott, FB, et, al. Rescue procedure: an alternative to complete removal for treatment of infected penile prosthesis. J Urol 1987; 137:202A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/43\">",
"      Henry GD, Wilson SK, Delk JR 2nd, et al. Penile prosthesis cultures during revision surgery: a multicenter study. J Urol 2004; 172:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/44\">",
"      Hauri D. Penile revascularization surgery in erectile dysfunction. Urol Int 2003; 70:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/45\">",
"      Peppas DS, Moul JW, McLeod DG. Candida albicans corpora abscess following penile prosthesis placement. J Urol 1988; 140:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/46\">",
"      Carson CC. Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res 2003; 15 Suppl 5:S139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/47\">",
"      DePalma RG, Olding M, Yu GW, et al. Vascular interventions for impotence: lessons learned. J Vasc Surg 1995; 21:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/48\">",
"      Parsons CL, Stein PC, Dobke MK, et al. Diagnosis and therapy of subclinically infected prostheses. Surg Gynecol Obstet 1993; 177:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/49\">",
"      Silverstein AD, Henry GD, Evans B, et al. Biofilm formation on clinically noninfected penile prostheses. J Urol 2006; 176:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/50\">",
"      Brant MD, Ludlow JK, Mulcahy JJ. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis. J Urol 1996; 155:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/51\">",
"      Henry GD, Wilson SK, Delk JR 2nd, et al. Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study. J Urol 2005; 173:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/52\">",
"      Mulcahy JJ. Surgical management of penile prosthesis complications. Int J Impot Res 2000; 12 Suppl 4:S108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/53\">",
"      Cookson MS, Phillips DL, Huff ME, Fitch WP 3rd. Analysis of microsurgical penile revascularization results by etiology of impotence. J Urol 1993; 149:1308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/54\">",
"      Vardi Y, Gruenwald I, Gedalia U, et al. Evaluation of penile revascularization for erectile dysfunction: a 10-year follow-up. Int J Impot Res 2004; 16:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/55\">",
"      Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol 2005; 174:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/56\">",
"      Rao DS, Donatucci CF. Vasculogenic impotence. Arterial and venous surgery. Urol Clin North Am 2001; 28:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/57\">",
"      Babaei AR, Safarinejad MR, Kolahi AA. Penile revascularization for erectile dysfunction: a systematic review and meta-analysis of effectiveness and complications. Urol J 2009; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/58\">",
"      Goldstein I. Overview of types and results of vascular surgical procedures for impotence. Cardiovasc Intervent Radiol 1988; 11:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/59\">",
"      Machtens S, G&auml;nsslen A, Pohlemann T, Stief CG. Erectile dysfunction in relation to traumatic pelvic injuries or pelvic fractures. BJU Int 2001; 87:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/60\">",
"      Kawanishi Y, Kimura K, Nakanishi R, et al. Penile revascularization surgery for arteriogenic erectile dysfunction: the long-term efficacy rate calculated by survival analysis. BJU Int 2004; 94:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/61\">",
"      Sarramon JP, Malavaud B, Bertrand N, Rischmann P. [Vascular microsurgery in the treatment of vasculogenic erectile dysfunction: clinical experience apropos of 115 operations performed according to 2 different surgical techniques]. Prog Urol 1999; 9:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/62\">",
"      Trombetta C, Liguori G, Siracusano S, et al. Laparoscopically assisted penile revascularization for vasculogenic impotence: 2 additional cases. J Urol 1997; 158:1783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/17/16664/abstract/63\">",
"      Munarriz R, Uberoi J, Fantini G, et al. Microvascular arterial bypass surgery: long-term outcomes using validated instruments. J Urol 2009; 182:643.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8092 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-197.136.42.3-2402AFD0B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16664=[""].join("\n");
var outline_f16_17_16664=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Medical risk evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Antimicrobial prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Patient counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PENILE PROSTHESES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Types",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Semi-rigid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Inflatable",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Antimicrobial coated implants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Choice of implant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Considerations for Peyronie's disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Implant complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PENILE REVASCULARIZATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Penile implants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Penile revascularization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8092\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8092|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/3/11319\" title=\"figure 1\">",
"      Anatomy of the penis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/52/5952\" title=\"figure 2\">",
"      Inflatable penile implant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8092|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/6/29796\" title=\"picture 1\">",
"      Malleable penile prosthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/33/33298\" title=\"picture 2\">",
"      Two piece penile prosthesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/21/38239\" title=\"picture 3\">",
"      Three piece penile prosthesis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/49/32533?source=related_link\">",
"      Evaluation of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/44/42696?source=related_link\">",
"      Overview of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29688?source=related_link\">",
"      Perioperative management of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42007?source=related_link\">",
"      Surgical management of Peyronie's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=related_link\">",
"      Treatment of male sexual dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_17_16665="Paraneoplastic pemphigus bullae";
var content_f16_17_16665=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F67265%7EDERM%2F79192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F67265%7EDERM%2F79192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vesicles and flaccid bullae are present on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Paraneoplastic pemphigus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bullae, erosions, and crusts are present on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16665=[""].join("\n");
var outline_f16_17_16665=null;
var title_f16_17_16666="Angiostrongylus costaricensis biopsy";
var content_f16_17_16666=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63616&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 567px\">",
"   <div class=\"ttl\">",
"    Angiostrongylus costaricensis biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 547px; height: 457px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B) Female",
"    <em>",
"     Angiostrongylus costaricensis",
"    </em>",
"    in an appendix biopsy, stained with hematoxylin and eosin (H&amp;E). Notice the thick, multinucleated intestine (IN), reproductive tubes (RT), eggs (EG) within the uterus (UT), and lateral chords (LC).",
"    <br>",
"     (C)",
"     <em>",
"      Angiostrongylus costaricensis",
"     </em>",
"     eggs in tissue, stained with H&amp;E.",
"     <br>",
"      (D)",
"      <em>",
"       Angiostrongylus costaricensis",
"      </em>",
"      larva in tissue sections stained with H&amp;E.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Angiostrongyliasis. Available at:",
"       <a href=\"file://dpd.cdc.gov/dpdx/html/Angiostrongyliasis.htm\" target=\"_blank\">",
"        file://dpd.cdc.gov/dpdx/html/Angiostrongyliasis.htm",
"       </a>",
"       .",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16666=[""].join("\n");
var outline_f16_17_16666=null;
var title_f16_17_16667="Sickle trait alpha thalassemia";
var content_f16_17_16667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F70184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F70184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hematologic parameters in sickle cell trait-alpha thalassemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Alpha globin genes",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hemoglobin (g/dL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        MCV (fL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hemoglobin S (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        13-15",
"       </td>",
"       <td>",
"        80-90",
"       </td>",
"       <td>",
"        35-45",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        13-14",
"       </td>",
"       <td>",
"        75-85",
"       </td>",
"       <td>",
"        30-35",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        12-13",
"       </td>",
"       <td>",
"        70-75",
"       </td>",
"       <td>",
"        25-30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        7-10",
"       </td>",
"       <td>",
"        50-55",
"       </td>",
"       <td>",
"        17-25",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    This table shows the effect of the number of functioning alpha globin genes on hematologic parameters in patients with the combination of alpha thalassemia and sickle cell trait. (The absence of any functional alpha globin genes is incompatible with extrauterine life; the normal complement is four.)",
"    <div class=\"footnotes\">",
"     MCV: mean corpuscular volume.",
"    </div>",
"    <div class=\"reference\">",
"     Data from Steinberg, MH and Embury, SH. Blood 1986; 68:985.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16667=[""].join("\n");
var outline_f16_17_16667=null;
var title_f16_17_16668="Drawing up insulin PI";
var content_f16_17_16668=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F54094&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F54094&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Technique for drawing up insulin",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Gather injection supplies, including insulin bottle(s), syringe, alcohol swab, and diabetes log book. Wash hands with soap and water or alcohol-based hand gel.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clean the rubber top of the insulin bottle(s) with alcohol swab. New bottles of insulin may have a hard plastic cap that must be snapped off to reveal the rubber top.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove the syringe cap. Pull on the plunger to draw air into the syringe, equal to the amount of insulin to be given. For example, if 10 units of insulin will be given, draw back 10 units of air.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insert the needle into the insulin bottle and depress the plunger, injecting the air into the bottle. If clear and cloudy insulin are used, inject air into the cloudy insulin first, followed by the clear insulin. Leave the needle inside the clear insulin bottle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hold the bottle with one hand and turn it upside down, keeping the needle inside the bottle. Slowly pull the plunger back to draw the correct insulin dose into the syringe.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Remove bubbles from the syringe, if needed. Bubbles are not harmful if injected subcutaneously, but they can decrease the amount of insulin in the syringe and potentially affect blood glucose levels.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Draw up insulin slowly and steadily. Bubbles form in the syringe if it is drawn up too quickly. If bubbles are seen, push the insulin back into the bottle and slowly re-draw. Do this as many times as needed until the bubbles are gone.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Draw two more units of insulin into the syringe than needed. If bubbles are seen, flick the syringe with the middle finger and thumb to make the bubbles rise. Once the bubbles are at the top, push the extra two units of insulin back into the bottle. Don't forget to push the extra insulin back into the vial - even if there are no air bubbles in the syringe.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If clear and cloudy insulin are used, it is only possible to remove bubbles from the clear insulin, which is drawn up first. Draw up cloudy insulin slowly and carefully to avoid forming bubbles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove the needle from the insulin bottle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If cloudy insulin is also needed, it must first be mixed. Gently turn the bottle up and down 20 times to mix it. Inject the needle into the cloudy insulin bottle. Carefully turn the bottle upside down (with the needle in place) and withdraw the dose needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Withdraw the needle from the insulin bottle and replace the needle cap.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16668=[""].join("\n");
var outline_f16_17_16668=null;
var title_f16_17_16669="Reading items figure for PedNIHSS";
var content_f16_17_16669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F83404&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F83404&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 601px\">",
"   <div class=\"ttl\">",
"    Reading items figure for PedNIHSS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 581px; height: 224px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;Words to test reading for Item 9 (Best language) of PedNIHSS",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ichord RN, Bastian R, Abraham L, et al. Interrater reliability of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) in a multicenter study. Stroke 2011; 42:613. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16669=[""].join("\n");
var outline_f16_17_16669=null;
var title_f16_17_16670="Rand trials adjuv chemo gast CA";
var content_f16_17_16670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F71898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F71898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Randomized trials of surgery with and without adjuvant combination chemotherapy in resected gastric cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"22%\">",
"     </colgroup>",
"     <colgroup width=\"12%\">",
"     </colgroup>",
"     <colgroup span=\"2\" width=\"22%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Author, year",
"       </td>",
"       <td class=\"subtitle1\">",
"        Country",
"       </td>",
"       <td class=\"subtitle1\">",
"        n",
"       </td>",
"       <td class=\"subtitle1\">",
"        Chemotherapy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hazard ratio for survival (95% CI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Non-anthracycline-containing polychemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Huguier M; 1980",
"       </td>",
"       <td>",
"        France",
"       </td>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        5-FU, VBL, CTX",
"       </td>",
"       <td>",
"        No significant survival difference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Schlag P; 1982",
"       </td>",
"       <td>",
"        Germany",
"       </td>",
"       <td>",
"        98",
"       </td>",
"       <td>",
"        5-FU, BCNU",
"       </td>",
"       <td>",
"        0.66 (0.31-1.41)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Douglass H; 1982",
"       </td>",
"       <td>",
"        USA",
"       </td>",
"       <td>",
"        142",
"       </td>",
"       <td>",
"        5-FU, MeCCNU",
"       </td>",
"       <td>",
"        0.58 (0.35-0.95)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ochiai T; 1983",
"       </td>",
"       <td>",
"        Japan",
"       </td>",
"       <td>",
"        59",
"       </td>",
"       <td>",
"        MMC, 5-FU, Ara-C",
"       </td>",
"       <td>",
"        1.08 (0.5-2.31)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Higgins G; 1983",
"       </td>",
"       <td>",
"        USA",
"       </td>",
"       <td>",
"        134",
"       </td>",
"       <td>",
"        5-FU, MeCCNU",
"       </td>",
"       <td>",
"        0.94 (0.58-1.53)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Engstrom P; 1985",
"       </td>",
"       <td>",
"        USA",
"       </td>",
"       <td>",
"        180",
"       </td>",
"       <td>",
"        5-FU, MeCCNU",
"       </td>",
"       <td>",
"        0.94 (0.58-1.53)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Jakesz R; 1988",
"       </td>",
"       <td>",
"        Austria",
"       </td>",
"       <td>",
"        87",
"       </td>",
"       <td>",
"        Ara-C, MMC, 5-FU",
"       </td>",
"       <td>",
"        0.65 (0.38-1.13)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bonfanti G; 1988",
"       </td>",
"       <td>",
"        Italy",
"       </td>",
"       <td>",
"        144",
"       </td>",
"       <td>",
"        5-FU, MeCCNU",
"       </td>",
"       <td>",
"        0.97 (0.61-1.55)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Allum W; 1989",
"       </td>",
"       <td>",
"        UK",
"       </td>",
"       <td>",
"        271",
"       </td>",
"       <td>",
"        MMC, 5-FU",
"       </td>",
"       <td>",
"        0.99 (0.73-1.36)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Allum W; 1989",
"       </td>",
"       <td>",
"        UK",
"       </td>",
"       <td>",
"        270",
"       </td>",
"       <td>",
"        CTX, 5-FU, VCR, MTX",
"        <sup>",
"         &bull;",
"        </sup>",
"        then MMC, 5-FU",
"       </td>",
"       <td>",
"        1.01 (0.74-1.38)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nakajima T; 1999",
"       </td>",
"       <td>",
"        Japan",
"       </td>",
"       <td>",
"        573",
"       </td>",
"       <td>",
"        MMC, 5-FU, UFT",
"       </td>",
"       <td>",
"        0.74 (0.5-1.09)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cirera L; 1999",
"       </td>",
"       <td>",
"        Spain",
"       </td>",
"       <td>",
"        148",
"       </td>",
"       <td>",
"        MMC, Ftorafur",
"       </td>",
"       <td>",
"        0.60 (0.39-0.93)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nashimoto A; 2003",
"       </td>",
"       <td>",
"        Japan",
"       </td>",
"       <td>",
"        252",
"       </td>",
"       <td>",
"        MMC, 5-FU, Ara-C",
"       </td>",
"       <td>",
"        No significant survival difference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bang Y; 2012",
"       </td>",
"       <td>",
"        Korea",
"       </td>",
"       <td>",
"        1035",
"       </td>",
"       <td>",
"        Capecitabine, oxaliplatin",
"       </td>",
"       <td>",
"        0.72 (0.52-1.00)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Anthracycline-containing polychemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Coombes R; 1990",
"       </td>",
"       <td>",
"        UK",
"       </td>",
"       <td>",
"        281",
"       </td>",
"       <td>",
"        5-FU, DOX, MMC",
"       </td>",
"       <td>",
"        0.89 (0.66-1.21)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Krook J; 1991",
"       </td>",
"       <td>",
"        USA",
"       </td>",
"       <td>",
"        125",
"       </td>",
"       <td>",
"        5-FU, DOX",
"       </td>",
"       <td>",
"        0.97 (0.62-1.51)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hallissey M; 1994",
"       </td>",
"       <td>",
"        UK",
"       </td>",
"       <td>",
"        283",
"       </td>",
"       <td>",
"        5-FU, DOX, MMC",
"       </td>",
"       <td>",
"        0.95 (0.74-1.22)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Macdonald J; 1995",
"       </td>",
"       <td>",
"        USA",
"       </td>",
"       <td>",
"        193",
"       </td>",
"       <td>",
"        5-FU, DOX, MMC",
"       </td>",
"       <td>",
"        0.91 (0.65-1.28)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lise M; 1995",
"       </td>",
"       <td>",
"        Italy",
"       </td>",
"       <td>",
"        294",
"       </td>",
"       <td>",
"        5-FU, DOX, MMC",
"       </td>",
"       <td>",
"        0.86 (0.64-1.14)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tsavaris N; 1996",
"       </td>",
"       <td>",
"        Greece",
"       </td>",
"       <td>",
"        84",
"       </td>",
"       <td>",
"        5-FU, EPI, MMC",
"       </td>",
"       <td>",
"        0.76 (0.31-1.87)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neri B; 1996",
"       </td>",
"       <td>",
"        Italy",
"       </td>",
"       <td>",
"        103",
"       </td>",
"       <td>",
"        5-FU, LV, EPI",
"       </td>",
"       <td>",
"        0.46 (0.27-0.77)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Di Costanzo F; 2008",
"       </td>",
"       <td>",
"        Italy",
"       </td>",
"       <td>",
"        258",
"       </td>",
"       <td>",
"        PELF",
"       </td>",
"       <td>",
"        0.91 (0.64-1.26)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bouche O; 2005",
"       </td>",
"       <td>",
"        France",
"       </td>",
"       <td>",
"        260",
"       </td>",
"       <td>",
"        Infusional 5-FU, CIS",
"       </td>",
"       <td>",
"        0.74 (0.54-1.02)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nitti D; 2006",
"       </td>",
"       <td>",
"        EORTC",
"       </td>",
"       <td>",
"        206",
"       </td>",
"       <td>",
"        5-FU, DOX, MTX",
"       </td>",
"       <td>",
"        0.89 (0.51-1.31)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nitti D; 2006",
"       </td>",
"       <td>",
"        ICCG",
"       </td>",
"       <td>",
"        191",
"       </td>",
"       <td>",
"        5-FU, EPI, MTX",
"       </td>",
"       <td>",
"        1.05 (0.69-1.41)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        De Vita F; 2007",
"       </td>",
"       <td>",
"        GOIM",
"       </td>",
"       <td>",
"        228",
"       </td>",
"       <td>",
"        5-FU, LV, EPI, ETOP",
"       </td>",
"       <td>",
"        0.91 (0.69-1.21)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kulig J; 2010",
"       </td>",
"       <td>",
"        Poland",
"       </td>",
"       <td>",
"        309",
"       </td>",
"       <td>",
"        EAP",
"       </td>",
"       <td>",
"        0.889 (0.676-1.169)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        S-1 monotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sasako M; 2011",
"       </td>",
"       <td>",
"        Japan",
"       </td>",
"       <td>",
"        1059",
"       </td>",
"       <td>",
"        S-1",
"       </td>",
"       <td>",
"        0.67 (0.54-0.83)*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MMC: mitomycin C; 5-FU: 5-fluorouracil; VBL: vinblastine; CTX: cyclophosphamide; Ara C: cytarabine; VCR: vincristine; MTX: methotrexate; UFT: ftorafur and uracil; DOX: doxorubicin; EPI: epirubicin; LV: leucovorin; CIS: cisplatin; PELF: cisplatin, epirubicin, leucovorin, 5-FU; ETOP: etoposide; EORTC: European Organization for Research and Treatment of Cancer; ICCG: International Collaborative Cancer Group; GOIM: Grupopa Oncologico dell'Italia Meridionale; EAP: etoposide, doxorubicin, cisplatin.",
"     <br/>",
"     * Statistically significant values for survival.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Induction chemotherapy with five days of CTX, 5-FU, VCR, and MTX, followed by MMC and 5-FU.",
"     <br/>",
"     &Delta; Both trials reported together, neither of which reached its accrual goal (760 for the EORTC and 480 for the ICCG trials).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16670=[""].join("\n");
var outline_f16_17_16670=null;
var title_f16_17_16671="DKA nomogram sodium";
var content_f16_17_16671=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64779&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nomogram of anticipated serum Na+ versus serum glucose during DKA treatment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 624px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     Panel A)",
"    </strong>",
"    Nomogram of anticipated serum sodium versus serum glucose during insulin treatment. This figure depicts the anticipated rise in the plasma sodium concentrations with the correction of hyperglycemia in diabetic ketoacidosis. Because a particular child may have greater or lesser losses of free water before presentation, the initial point plotted may be at different starting positions. However, whatever the starting position, the rise in plasma glucose should be along a line parallel to the isobars (green dashed lines), because the Na+ will rise by approximately 2.4 mEq/L for every 100 mg/dL fall in plasma glucose.",
"    <strong>",
"     Panel B)",
"    </strong>",
"    Example of the use of the nomogram of anticipated serum sodium versus glucose during insulin treatment. For a typical patient, the measured serum sodium will rise as expected (blue circles). If the patient's sodium does not rise as expected as the glucose falls (red triangles), the child may have been given excessive free water.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_17_16671=[""].join("\n");
var outline_f16_17_16671=null;
